In our latest episode, Arnout discusses how markets are repositioning in line with Fed hawkishness and a US sovereign debt downgrade; he looks at economic and financial news out of China that points to a steadily weakening economy; warns about the risks of concentration in equity portfolios and talks about how investing in consumer health has taken a new turn, as drugs companies showcase the therapeutic benefits of prescription obesity medication.

Length without disclaimer: 15 minutes.

This podcast features material by fair use guidelines. All rights reserved to the copyright owners